## TDY: Teledyne Technologies Incorporated - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.98 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($497.02)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. From Pentagon to NASA to defense tech: Dr. JihFen Lei’s new Teledyne role**
- Source: Stock Titan | 20251222T215104 | Bullish | Relevance: 100%
- Teledyne Technologies Incorporated has announced the promotion of Dr. JihFen Lei to Senior Vice President, effective January 1, 2026. In her expanded role, Dr. Lei will continue to lead Teledyne FLIR Defense and will assume responsibility for Teledyne’s Aerospace and Defense Electronics Segment, collectively forming the Teledyne Defense and Aerospace Group. This promotion recognizes her strong leadership and ability to deliver advanced solutions for global defense customers.

**2. Voya Investment Management LLC Cuts Stock Holdings in Teledyne Technologies Incorporated $TDY**
- Source: MarketBeat | 20251222T125159 | Somewhat-Bullish | Relevance: 100%
- Voya Investment Management LLC reduced its stake in Teledyne Technologies (NYSE:TDY) by 13.5% in the third quarter, selling 4,969 shares and now holding 31,961 shares valued at $18.73 million. Teledyne Technologies reported strong Q3 earnings, exceeding EPS expectations and showing a 6.7% increase in revenue year-over-year. The stock has a "Moderate Buy" consensus from analysts, with institutional investors owning 91.58% of the company's shares.

**3. Teledyne Technologies Incorporated (NYSE:TDY) Receives Consensus Recommendation of "Moderate Buy" from Brokerages**
- Source: MarketBeat | 20251220T070042 | Bullish | Relevance: 100%
- Teledyne Technologies Incorporated (NYSE:TDY) has received a "Moderate Buy" consensus recommendation from nine brokerages, with an average one-year price target of $601.3750. Analyst firms like Stifel Nicolaus, Needham & Company LLC, Citigroup, Barclays, and Morgan Stanley have provided price target adjustments and ratings. The company's stock shows strong financials, including a market cap of $23.95 billion and recent positive quarterly earnings surpassing analyst estimates.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | Citigroup | $567 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | Citigroup | init | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (+1.2%)
- Blackrock Inc.: 8.7% (+0.1%)
- Price (T.Rowe) Assoc: 7.0% (+5.1%)
- State Street Corpora: 4.7% (+2.8%)
- JPMORGAN CHASE & CO: 4.0% (+105.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.98 indicates undervaluation relative to growth. Forward P/E 21.9x stretched relative to 10% growth. Balance sheet: low leverage (D/E 0.46). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $24.3B |
| Beta | 1.03 |
| 52W Range | $419.00 - $595.99 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.98 |
| Forward P/E | 21.9 |
| Current P/E | 24.0 |
| YoY Growth | 9.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 improving modestly (+1.0% over 5 days). Below STRENGTH zone by 2.7pp (needs >4.0% for momentum thesis). MRS_5 at 0.5% confirms short-term momentum alignment. Below SMA200 (1.00x), long-term trend not supportive. MACD histogram positive (1.30), confirming momentum. RSI neutral at 54. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.34% (CS: 61) | Neutral |
| RSI_14 | 54.0 | Neutral |
| MACD Histogram | 1.30 | Bullish |
| vs SMA20 | 1.019x | Above |
| vs SMA50 | 0.997x | Below |
| vs SMA200 | 1.000x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $517.82
- **Stop Loss:** $497.02 (4.0% risk)
- **Target:** $559.42 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 57
- **Position Value:** $29,515.74
- **Portfolio %:** 29.52%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-21 (Est: $5.85)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $5.47 | $5.57 | +1.8% |
| 2025Q2 | $5.05 | $5.20 | +3.0% |
| 2025Q1 | $4.92 | $4.95 | +0.6% |
| 2024Q4 | $5.23 | $5.52 | +5.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*